SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (15410)6/22/2001 3:24:34 PM
From: WL  Respond to of 17367
 
Link for BGEN results reported in NY times:

nytimes.com

In that article today, NY times reports that:

"One of the leading drugs, made by Biogen Inc., worked very well in only 14 percent of patients after one course of treatment, a lower rate than the 30 percent seen in earlier trials."



To: aknahow who wrote (15410)6/22/2001 3:46:39 PM
From: Cacaito  Read Replies (1) | Respond to of 17367
 
Monday follow trough will determine closing or not the short, $15 showed today a torrent of selling, it cool down the price pressure in few minutes. The TSC seems now allied with xoma in a bear trap! Gw seems involved in liking xoma.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News